Literature DB >> 6405018

Effects of 6-hydroxydopamine on visual deprivation in the kitten striate cortex.

N W Daw, R K Rader, T W Robertson, M Ariel.   

Abstract

We tested the effects of 6-hydroxydopamine (6-OHDA) on two forms of visual deprivation--monocular and directional deprivation. In normal kittens monocular deprivation leads to a change in the ocular dominance histogram recorded from the visual cortex, and directional deprivation leads to a change in the percentage of directionally sensitive cells responding to the appropriate direction of movement. 6-OHDA was infused into the occipital cortex prior to the peak of the critical period for the effects of visual deprivation. In agreement with the results of Kasamatsu et al. (Kasamatsu, T., and J. D. Pettigrew (1979) J. Comp. Neurol. 185: 139-162; Kasamatsu, T., J. D. Pettigrew, and M. Ary (1979) J. Comp. Neurol. 185: 163-182), suture of one eye (monocular deprivation) after the 6-OHDA treatment did not lead to a shift in ocular dominance in the area of striate cortex infused. Moreover, rearing kittens in an environment continually moving past them in one direction (directional deprivation) did not lead to a change in the percentage of cells preferring movement in that direction. In both rearing procedures the 6-OHDA did not make the cells in the cortex nonspecific, compared to cells recorded from the cortex of animals reared similarly but without infusion of 6-OHDA. Monocular and directional deprivation are forms of visual deprivation with different critical periods, probably involving different synapses. Therefore, the effect of 6-OHDA on visual deprivation is a general one, involving more than one kind of visual deprivation. In both cases 6-OHDA abolishes the plasticity of the visual cortex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405018      PMCID: PMC6564519     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

1.  Reemergence of ocular dominance plasticity during recovery from the effects of propranolol infused in kitten visual cortex.

Authors:  T Shirokawa; T Kasamatsu
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

2.  Changing patterns of binocular visual connections in the intertectal system during development of the frog, Xenopus laevis. III. Modifications following early eye rotation.

Authors:  S Grant; M J Keating
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  Involvement of beta-adrenoreceptors in the shift of ocular dominance after monocular deprivation.

Authors:  T Kasamatsu; T Shirokawa
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

4.  Norepinephrine is necessary for experience-dependent plasticity in the developing mouse auditory cortex.

Authors:  Kathryn N Shepard; L Cameron Liles; David Weinshenker; Robert C Liu
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

5.  Mutations in the dopa decarboxylase gene affect learning in Drosophila.

Authors:  B L Tempel; M S Livingstone; W G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Cortical activity blockade prevents ocular dominance plasticity in the kitten visual cortex.

Authors:  H O Reiter; D M Waitzman; M P Stryker
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

7.  Substantial reduction of noradrenaline in kitten visual cortex by intraventricular injections of 6-hydroxydopamine does not always prevent ocular dominance shifts after monocular deprivation.

Authors:  N W Daw; T O Videen; R K Rader; T W Robertson; C J Coscia
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

8.  Noradrenaline and functional plasticity in kitten visual cortex: a re-examination.

Authors:  J Adrien; G Blanc; P Buisseret; Y Frégnac; E Gary-Bobo; M Imbert; J P Tassin; Y Trotter
Journal:  J Physiol       Date:  1985-10       Impact factor: 5.182

Review 9.  The role of drug treatment in children with strabismus and amblyopia.

Authors:  K I Chatzistefanou; M D Mills
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.930

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.